ALK and non-small cell lung carcinoma: In addition, an emerging technique is the use of circulating tumour DNA to explore dynamic ALK on‐ and off‐target resistance mechanisms not captured in a single site tissue biopsy, noting that in NSCLC, on‐ and off‐target mechanisms often co‐occur [26].